GE HealthCare (GEHC) Up 7.5% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for GE HealthCare Technologies (GEHC). Shares have added about 7.5% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is GE HealthCare due for a pullback? Before we dive into how investors and analysts have reacted as of late, let’s take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.

GE HealthCare reported third-quarter 2025 adjusted earnings per share of $1.07, which beat the Zacks Consensus Estimate of $1.05 by 1.9%. However, the bottom line declined 6.1% year over year.

GAAP earnings per share in the quarter was 98 cents, down 3.9% from the year-ago level.

Revenues of $5.14 billion were up 6% year over year on a reported basis and 4% organically. The top line beat the Zacks Consensus Estimate by 1.4%. Total company orders increased 6% organically year over year.

Revenues were driven by strength in the U.S. market as well as in the EMEA markets.

Imaging

Revenues from this segment totaled $2.35 billion, up 5% year over year on a reported basis and 4% organically.

Segment EBIT was $240 million, down 16% year over year.

Advanced Visualization Solutions

Revenues totaled $1.3 billion, up 7% year over year on a reported basis and 6% on an organic basis.

Segment EBIT was $271 million, up 17% year over year.

Patient Care Solutions

Revenues amounted to $731 million, down 6% year over year on a reported basis and down 7% organically.

Segment EBIT was $27 million, down 67% year over year.

Pharmaceutical Diagnostics

Revenues totaled $749 million, up 20% year over year and 10% on an organic basis.

Segment EBIT was $220 million, up 14% year over year.

Net income margin was 8.7%, down 100 basis points from the prior-year level, due to unfavorable impact of tariffs, partially offset by benefits from volume and price.

Cumulative cash flow from operating activities at the end of the third quarter was $937 million compared with $1.04 billion a year ago.

GEHC exited the third quarter with cash, cash equivalents and investments of $4.03 billion compared with $3.76 billion in the previous quarter.

Total assets increased to $36.13 billion from $35.5 billion on a sequential basis.

GE HealthCare updated its earnings guidance for 2025.

The company now expects adjusted earnings per share to be in the range of $4.51-$4.63 compared with the previous guidance of $4.43-$4.63. The guidance includes approximately 45 cents of unfavorable impact of tariffs. The company continues to estimate revenue growth at 3% organically.